Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
304.29B | 276.08B | 252.71B | 226.34B | 213.00B | 204.47B | Gross Profit |
66.84B | 63.87B | 57.91B | 51.63B | 40.28B | 32.59B | EBIT |
29.50B | 29.11B | 27.22B | 23.55B | 14.25B | 8.23B | EBITDA |
60.16B | 58.88B | 56.87B | 55.50B | 43.00B | 36.26B | Net Income Common Stockholders |
20.64B | 19.83B | 18.85B | 15.67B | 9.71B | 4.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
37.98B | 45.47B | 44.39B | 48.69B | 44.44B | 41.34B | Total Assets |
307.67B | 273.71B | 246.19B | 231.81B | 220.78B | 206.52B | Total Debt |
33.63B | 30.18B | 20.43B | 21.87B | 25.56B | 27.75B | Net Debt |
-1.18B | -15.29B | -22.04B | -25.52B | -16.91B | -10.92B | Total Liabilities |
169.75B | 146.68B | 126.89B | 127.18B | 129.81B | 126.47B | Stockholders Equity |
136.55B | 125.75B | 118.12B | 103.53B | 89.96B | 79.08B |
Cash Flow | Free Cash Flow | ||||
11.64B | 21.84B | 21.27B | 32.05B | 29.54B | 21.55B | Operating Cash Flow |
32.52B | 40.78B | 38.53B | 43.57B | 40.54B | 33.39B | Investing Cash Flow |
-22.74B | -17.93B | -18.39B | -11.84B | -13.22B | -7.26B | Financing Cash Flow |
-17.19B | -20.80B | -25.73B | -27.30B | -23.62B | -19.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $510.62B | 25.18 | 14.78% | 1.18% | 14.76% | 0.69% | |
61 Neutral | $14.60B | 5.95 | -4.32% | 3.69% | 2.76% | -30.49% | |
$2.58B | 29.15 | 15.57% | 1.13% | ― | ― | ||
$63.08B | 14.73 | 13.04% | 2.94% | ― | ― | ||
79 Outperform | ¥18.65B | 10.27 | 3.67% | 6.35% | 54.17% | ||
76 Outperform | ¥27.21B | 31.99 | ― | 24.84% | -38.04% | ||
68 Neutral | ¥9.28B | 24.32 | 1.32% | 4.70% | 35.62% |